Danaher (FRA:DAP) Other Financing: €-153 Mil (TTM As of Mar. 2026)


FRA:DAP Danaher Corp FRA:DAP
76 GF Score
Price €169.00
GF Value €207.79
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Danaher Other Financing?

Danaher FRA:DAP -0.03% 76 Other Financing is €-153 Mil as of Mar. 2026. GuruFocus rates FRA:DAP with a GF Score™ of 76/100 and a GF Value™ of €207.79 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Danaher's Other Financing for the three months ended in Mar. 2026 was €-32 Mil.

Danaher's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was €-153 Mil.


Danaher Other Financing Historical Data

* Premium members only.

The historical data trend for Danaher's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danaher Other Financing Chart

Danaher Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.16 -89.68 2,322.76 -125.11 -106.75

Danaher Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.80 -17.34 -55.38 -47.82 -32.01
FRA:DAP
76GF Score
Danaher Corp FRA:DAP
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danaher Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-153 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €-153 Mil mean?
Danaher (FRA:DAP) has a Other Financing of €-153 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Danaher and its competitors.
Is Danaher's Other Financing too high?
Danaher's current Other Financing is €-153 Mil. Overall, Danaher has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Danaher's Other Financing compare to TMO and IDXX?
Danaher's Other Financing of €-153 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Diagnostics & Research company?
A good Other Financing depends on the Medical Diagnostics & Research industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Danaher and its competitors. Danaher's current Other Financing is €-153 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danaher stock overvalued right now?
Based on GuruFocus' analysis, Danaher (FRA:DAP) is currently considered Modestly Undervalued. The stock's GF Value™ is €207.79, compared to a current price of €169.00 — trading 18.7% below its estimated fair value. The current Other Financing is €-153 Mil. Danaher's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Danaher (FRA:DAP), the current Other Financing is €-153 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Danaher (FRA:DAP) Overvalued in 2026?

Based on GuruFocus' analysis, Danaher stock appears to be undervalued. The current stock price of €169.00 is trading 18.7% below its estimated GF Value™ of €207.79. GuruFocus considers Danaher to be Modestly Undervalued.

Key valuation signals for FRA:DAP:

  • Other Financing: €-153 Mil
  • GF Value™: €207.79 vs. price of €169.00 (18.7% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the FRA:DAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Danaher Business Description

Address 2200 Pennsylvania Avenue, NW, Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
76GF Score

Get the complete analysis for FRA:DAP

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€169.00
Price
€207.79
GF Value